Differential progression of unhealthy dietinduced hepatocellular carcinoma in obese and non-obese mice

Authors

Emma Hymel, University of Nebraska Medical Center
Elizabeth Vlock, University of Nebraska-LincolnFollow
Kurt W. Fisher, University of Nebraska Medical CenterFollow
Paraskevi A. Farazi, University of Nebraska-LincolnFollow

ORCID IDs

Kurt W. Fisher https://orcid.org/0000-0002-8391-390X

Paraskevi A. Farazi https://orcid.org/0000-0002-4375-5812

Document Type

Article

Date of this Version

8-22-2022

Citation

Hymel E, Vlock E, Fisher KW, Farazi PA (2022) Differential progression of unhealthy dietinduced hepatocellular carcinoma in obese and non-obese mice. PLoS ONE 17(8): e0272623. https://doi.org/10.1371/journal.pone.0272623

Comments

Copyright: © 2022 Hymel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License,

Abstract

Background Non-alcoholic fatty liver disease (NAFLD) ranks first among liver diseases in Western countries. NAFLD is typically associated with obesity and diabetes, however it also develops in lean individuals without metabolic syndrome. The prevalence of lean NAFLD is 7 percent in the U.S. and 25–30 percent in some Asian countries. NAFLD starts with excess liver fat accumulation (NAFL), progresses to nonalcoholic steatohepatitis (NASH), cirrhosis and hepatocellular carcinoma (HCC). The pathogenesis of lean NASH-HCC and how it differs from obese NASH-HCC is not well understood.

Methods In this work, we generated a mouse model of lean and obese NASH-HCC using a choline deficient/high trans-fat/fructose/cholesterol diet and a choline supplemented/high trans-fat/ fructose/cholesterol diet, respectively, to compare progression to NASH-HCC in lean versus obese mice. Comparisons were made at the organismal, histological, and molecular level by investigating fatty acid metabolism in the plasma of these mice.

Results Obese mice showed more pronounced glucose intolerance and insulin resistance, higher levels of plasma cholesterol and triglycerides, and higher penetrance of NASH compared to lean mice. Despite the abnormal metabolic profile of obese mice, male obese and lean mice developed HCC with similar penetrance (53.3% and 53.8%, respectively), albeit lean mice showed faster tumor progression as evidenced by the larger tumor size and lower HCC-free survival. None of the female lean mice developed HCC, while 50% of female obese mice developed HCC. Both groups of mice showed a reduction in plasma polyunsaturated fatty acids (PUFAs), however, the levels were higher towards the endpoint in obese mice compared to lean mice.

Conclusions Unhealthy diet composition appears to drive progression to NASH-HCC rather than the organismal effects of obesity. PUFA levels may increase due to systemic inflammation in obese mice and act as suppressors of tumor progression, thus delaying HCC progression in obese mice compared to lean mice. These models could be used to further dissect the molecular pathogenesis of lean and obese NASH-HCC and address the mechanisms whereby PUFAs may be implicated in hepatocarcinogenesis.